Skip to content
Menu

Regencell Bioscience Holdings Limited RGC

Full chart Compare
Set alert

Price alert · RGC

All alert types
4.94 USD -0.18 (-3.61%)

Regular-session close

5.10 +0.16 +3.24%

After hours · Nov 13, 7:48 PM ET

4.71 Day range 5.08
4.78 52-week range 52.88
YTD
-76.48%
1 year
-62.00%
Market cap
2.45B
EPS (ttm)
-0.02
Shares out
495.88M
YTD return
-76.48%
1-year return
-62.00%
Volume
119.34K
Avg volume
240.17K
Open
5.08
Previous close
5.13
Day's range
4.71 – 5.08
52-week range
4.78 – 52.88
Beta
1.71

5D -0.46 (-8.52%)

55.50MonTueWedThuFri4.94

Key statistics

Enterprise value
2.53B
PEG ratio
0.00
Price / sales
0.00
Price / book
182.96
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
0.00%
Free cash flow
-2.99M
Total cash
14.19M
Total debt
295.81K
Return on equity
-128.53%
Short % of float
0.63%
50-day average
6.82
200-day average
16.10

Financials — quick view

All financials
RGC Revenue — annual 0
2019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 20252026-FY 2026
RGC Net income — annual -11.70M
2019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 20252026-FY 2026
RGC EPS — annual -0.024
2019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 20252026-FY 2026

Earnings

RGC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Oct 28, 2026Jun 30, 2026—-0.0129——
Jun 15, 2026Dec 31, 2025—-0.0107——
Nov 18, 2025Jun 30, 2025—-0.0035——
Jun 26, 2025Dec 29, 2024—-0.14244——
Oct 25, 2024Jun 30, 2024—-0.0045——
Jan 26, 2024Dec 30, 2023—0.00——

About Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Hong Kong

News

Your note

Sign in to keep a note on RGC — it syncs with the Stock Master app.

Institution ownership

RGC institution ownership
Holder% heldSharesValueReported
Geode Capital Management, LLC0.09%423,3702.09MSep 29, 2026
Alyeska Investment Group, L.p.0.08%416,2612.06MJun 29, 2026
Legal & General Group PLC0.03%128,000632.32KJun 29, 2026
Jane Street Group, LLC0.02%81,697403.58KSep 29, 2026
Quadrature Capital Ltd0.01%41,750206.25KJun 29, 2026
Xtx Topco Ltd0.01%60,061296.70KJun 29, 2026

Fund ownership

RGC fund ownership
Holder% heldSharesValueReported
Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund0.06%301,8591.49MSep 29, 2026
Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF0.02%121,511600.26KSep 29, 2026
John Hancock Variable Insurance Trust-Total Stock Market Index Trust0.00%7,60237.55KJun 29, 2026
Invesco Exch-Trd Fd. TRT II-Invesco S&P Emerging Markets Momentum ETF0.00%4782.36KAug 30, 2026
SPDR INDEX SHARES FUNDS-State Street SPDR S&P China ETF0.00%4,05120.01KSep 29, 2026